Radioiodinated recombinant human TSH: a novel radiopharmaceutical for thyroid cancer metastases detection.
UNLABELLED: The follow-up of differentiated thyroid cancer (DTC) is currently performed by serum Tg levels determination and whole body scan (WBS) with 131I. In this regard, the latter represents the main tool to localize metastatic tissue, but is characterized by the induction of severe hypothyroi...
Main Authors: | Corsetti, F, Chianelli, M, Cornelissen, B, Van de Wiele, C, D'Alessandria, C, Slegers, G, Mather, S, Di Mario, U, Filetti, S, Scopinaro, F, Signore, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2004
|
Similar Items
-
Radiolabelled rhTSH for the diagnosis of metastases in differentiated thyroid cancer
by: Corsetti, F, et al.
Published: (2003) -
I-123-labelled interleukin-12, a new radiopharmaceutical for imaging Th1-mediated chronic inflammation: In vitro and animal studies
by: Annovazzi, A, et al.
Published: (2003) -
Synthesis of Tc-99m-Hynic-interleukin-12, a new radiopharmaceutical for imaging Th-1-lymphocytes
by: Annovazzi, A, et al.
Published: (2004) -
Synthesis of 99mTc-HYNIC-interleukin-12, a new specific radiopharmaceutical for imaging T lymphocytes.
by: Annovazzi, A, et al.
Published: (2006) -
In vivo apoptosis detection with radioiodinated Annexin V in LoVo tumour-bearing mice following Tipifarnib (Zarnestra, R115777) farnesyltransferase inhibitor therapy.
by: Cornelissen, B, et al.
Published: (2005)